Skip to main content
. 2021 May 10;12:607026. doi: 10.3389/fphar.2021.607026

FIGURE 3.

FIGURE 3

Effect of SF1 treatment (40 mg/kg) on skeletal anomalies in the teratogenic study. (A): no ribs fusion, (B): ossified hind limb bone, (C): ossified bone of forelimb, (D): normal legs bone, (E): palate bone, (F): normal cleft palate, (G): tail bone, (H): lower vertebral column.